CIBC Private Wealth Group
HRMY icon

CIBC Private Wealth Group’s Harmony Biosciences HRMY Stock Holding History

CIBC Private Wealth Group’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$130K Sell
3,477
-16,756
-83% -$551K ﹤0.01% 1389
2025
Q3 		$558K Buy
20,233
+16,865
+501% +$581K ﹤0.01% 829
2025
Q2 		$106K Buy
3,368
+58
+2% +$1.87K ﹤0.01% 1355
2025
Q1 		$93.1K Sell
3,310
-904
-21% -$32.4K ﹤0.01% 1387
2024
Q4 		$146K Buy
4,214
+1,681
+66% +$57.8K ﹤0.01% 1283
2024
Q3 		$101K Buy
2,533
+1,033
+69% +$36.3K ﹤0.01% 1474
2024
Q2 		$48.8K Buy
1,500
+82
+6% +$2.47K ﹤0.01% 1688
2024
Q1 		$46.8K Buy
+1,418
New +$45.5K ﹤0.01% 1710
2022
Q2 		– Sell
-11,434
Closed -$557K – 1243
2022
Q1 		$557K Sell
11,434
-48,566
-81% -$1.98M ﹤0.01% 728
2021
Q4 		$2.56M Hold
60,000
– – 0.01% 488
2021
Q3 		$2.3M Buy
60,000
+1,000
+2% +$32.2K 0.01% 487
2021
Q2 		$1.67M Buy
+59,000
New +$1.77M ﹤0.01% 560

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CIBC Private Wealth Group's HRMY Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its Harmony Biosciences (HRMY) stake by 83% in Q4 2025, selling an estimated $551K and leaving 3,477 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #1389.

CIBC Private Wealth Group first reported a position in HRMY in Q2 2021 and has held it in 12 quarters since. The position peaked at $2.56M in Q4 2021. 323 funds tracked by Wall St. Rank hold HRMY as of Q4 2025.

  • CIBC Private Wealth Group held 3,477 shares of Harmony Biosciences worth $130K as of Q4 2025.
  • CIBC Private Wealth Group sold 16,756 Harmony Biosciences shares in Q4 2025, an estimated $551K.
  • Harmony Biosciences made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1389 holding.
  • CIBC Private Wealth Group first reported a position in Harmony Biosciences in Q2 2021 and has held it in 12 quarters since.
  • CIBC Private Wealth Group's Harmony Biosciences position peaked at $2.56M in Q4 2021.
  • 323 funds tracked by Wall St. Rank held Harmony Biosciences as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.